4//SEC Filing
Huttner Kenneth 4
Accession 0000899243-19-004574
CIK 0001664106other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:10 PM ET
Size
5.3 KB
Accession
0000899243-19-004574
Insider Transaction Report
Form 4
Huttner Kenneth
SVP, Head of Clinical Dev.
Transactions
- Award
Stock Option (right to buy)
2019-02-20+50,818→ 50,818 totalExercise: $9.06Exp: 2029-02-19→ Common Stock (50,818 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% of the shares on the first anniversary of the grant date and in equal monthly installments over the next three years.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001768318
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 5:10 PM ET
- Size
- 5.3 KB